MedTrace Logo

Clinical Trial to Assess the Effects of Dairy on Insulin Sensitivity and β-Cell Function

NCT01936935 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2023-12-04

No results posted yet for this study

Summary

The aim of this trial is to evaluate the effects of dairy product consumption on insulin sensitivity and pancreatic β-cell function in men and women at risk for the development of type 2 diabetes mellitus (T2DM) who habitually consume beverages high in sugar (non-diet sodas and fruit juice cocktails).

Conditions

Interventions

OTHER

Low-fat dairy

2 servings/d of 2% non-flavored, unsweetened milk + 1 serving/d sweetened low-fat yogurt

OTHER

Sugar-sweetened beverages

2 servings/d of non-diet soda + 1 serving/d of non-dairy pudding

Sponsors & Collaborators

  • BioFortis

    collaborator OTHER

  • Dairy Research Institute

    collaborator OTHER

  • Provident Clinical Research

    lead OTHER

Principal Investigators

  • Kevin C Maki, PhD · Biofortis Clinical Research, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01936935 on ClinicalTrials.gov